镰状细胞病中胎儿血红蛋白的诱导 - Suppr

Induction of fetal hemoglobin in sickle cell disease.

作者信息

Bunn H F

机构信息

Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA.

出版信息

Blood. 1999 Mar 15;93(6):1787-9.

PMID:10068648

Abstract

摘要

相似文献

Induction of fetal hemoglobin in sickle cell disease.

Blood. 1999 Mar 15;93(6):1787-9.

Hydroxyurea induction of fetal hemoglobin synthesis in sickle-cell disease.

Semin Oncol. 1992 Jun;19(3 Suppl 9):61-6.

Reversing ontogeny.

N Engl J Med. 1993 Jan 14;328(2):129-31. doi: 10.1056/NEJM199301143280210.

Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease.

Curr Opin Hematol. 2001 Mar;8(2):123-30. doi: 10.1097/00062752-200103000-00010.

Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.

Blood. 1999 Mar 15;93(6):1790-7.

Intrapatient variability in fetal hemoglobin measurements over time in sickle cell patients not on fetal hemoglobin inducing agents.

Am J Hematol. 2016 Mar;91(3):E11-2. doi: 10.1002/ajh.24261.

Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.

Trans Assoc Am Physicians. 1984;97:268-74.

The biophysics of sickle cell hydroxyurea therapy.

Science. 1995 May 26;268(5214):1142-3. doi: 10.1126/science.7539154.

A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.

Am J Hematol. 2013 Nov;88(11):E255-60. doi: 10.1002/ajh.23533. Epub 2013 Oct 3.

Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.

Trans Assoc Am Physicians. 1984;97:140-5.

引用本文的文献

Study protocol for a randomized controlled trial to assess the feasibility of an open label intervention to improve hydroxyurea adherence in youth with sickle cell disease.

Contemp Clin Trials. 2016 Jul;49:134-42. doi: 10.1016/j.cct.2016.06.004. Epub 2016 Jun 17.

MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin.

Cell J. 2016 Winter;17(4):583-92. doi: 10.22074/cellj.2016.3808. Epub 2016 Jan 17.

Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells.

Mol Ther Methods Clin Dev. 2015 Dec 2;2:15045. doi: 10.1038/mtm.2015.45. eCollection 2015.

Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.

Exp Hematol. 2015 May;43(5):346-351. doi: 10.1016/j.exphem.2015.01.009. Epub 2015 Feb 12.

Transcriptional mechanisms underlying hemoglobin synthesis.

Cold Spring Harb Perspect Med. 2013 Sep 1;3(9):a015412. doi: 10.1101/cshperspect.a015412.

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia.

J Blood Med. 2011;2:23-30. doi: 10.2147/JBM.S14942. Epub 2011 Feb 28.

Effective control of sickle cell disease with hydroxyurea therapy.

Indian J Pharmacol. 2010 Feb;42(1):32-5. doi: 10.4103/0253-7613.62409.

Advances in management of sickle cell disease.

Indian J Pediatr. 2003 Aug;70(8):649-54. doi: 10.1007/BF02724255.

Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo.

Blood. 2002 Dec 15;100(13):4640-8. doi: 10.1182/blood-2002-02-0353. Epub 2002 Aug 15.

Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation.

Blood. 2001 May 15;97(10):3259-67. doi: 10.1182/blood.v97.10.3259.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Induction of fetal hemoglobin in sickle cell disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献